Role of Prognostic Scores in Managing Patients with Intracranial Hemorrhage
Prognostic scores such as the ICH score are recommended as part of the initial evaluation of patients with intracranial hemorrhage to provide an overall measure of clinical severity, but should not be used as the sole basis for limiting life-sustaining treatment. 1
Overview of Prognostic Scores for ICH
The ICH score is the most widely validated and utilized prognostic tool for intracranial hemorrhage patients. It incorporates five key components:
- Glasgow Coma Scale (GCS) score
- Age (≥80 years)
- ICH volume (≥30 cm³)
- Presence of intraventricular hemorrhage
- Infratentorial origin of hemorrhage
Each component contributes points to a total score ranging from 0-6, with higher scores correlating with increased mortality and poorer functional outcomes 2.
Clinical Applications of Prognostic Scores
Recommended Uses
Initial Clinical Assessment
- Provides standardized measure of hemorrhage severity
- Helps risk-stratify patients on presentation 1
- Facilitates communication between healthcare providers
Communication Framework
- Offers a general framework for discussions with patients and caregivers about severity 1
- Helps set realistic expectations while acknowledging limitations
Research and Quality Metrics
- Enables standardization in clinical trials
- Facilitates comparison across different studies and institutions 1
- Supports quality improvement initiatives
Important Limitations and Cautions
Not for Limiting Care
Potential for Bias
Evolving Outcomes
- Many patients continue to improve across the first year after ICH 4
- Improvement may continue even after 6 months post-ICH
Evidence-Based Best Practices
Initial Severity Assessment
- Administer baseline ICH score or similar validated tool during initial evaluation 1
- Document all components accurately (GCS, age, hemorrhage volume, IVH presence, location)
Avoid Premature Prognostication
Longitudinal Assessment
- Re-evaluate patients regularly as clinical status may improve over time 4
- Consider functional outcomes at multiple timepoints (discharge, 30 days, 3 months, 6 months, 12 months)
Shared Decision-Making
- Use a shared decision-making model between surrogates and physicians when patients cannot participate 1
- Present prognostic information as one factor among many in treatment decisions
Special Considerations
Pediatric Patients
- Consider hemorrhage volume as a percentage of total brain volume rather than absolute volume 1
- Use age-appropriate functional outcome measures like Pediatric Quality of Life score
Different ICH Subtypes
- Consider separate assessment for different categories: spontaneous non-coagulopathic ICH, coagulopathic ICH, traumatic ICH 1
- Location-specific considerations may be important (supratentorial vs. infratentorial)
Modified Scores
Common Pitfalls to Avoid
Overly Pessimistic Prognostication
Misinterpreting DNR Orders
Failing to Reassess
- Single time-point assessment may miss potential for recovery
- Significant improvement can occur after hospital discharge 4
In conclusion, prognostic scores provide valuable information for initial assessment and communication in ICH patients but should be used as part of a comprehensive approach to patient care rather than as the sole determinant of treatment decisions.